Top Markets
#1 Purr Purr +56.93%
#2 Pons Pons +55.24%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 StonkBroker StonkBroker +30.10%
#5 Non-Playable Coin Non-Playable Coin +27.00%
#6 TENDIES TENDIES +25.91%
#7 ApeX ApeX +24.91%
#8 Kinetiq Kinetiq +24.56%
#9 Morpho Morpho +22.71%
#10 OriginTrail OriginTrail +20.65%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Clasificación en acciones #21275
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Precio por acción
$10.04
Última sincronización: 2026-08-21
Capitalización bursátil
$111.12M
Cambio (1 día)
-1.43%
Cambio (1 año)
-40.73%
País
KR
Comercio Onconic Therapeutics (476060)

Categoría

Healthcare
Ratio P/S de Onconic Therapeutics (476060)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Onconic Therapeutics, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Onconic Therapeutics desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH